AU2000257080A1 - Fused protein with antitumor effect - Google Patents

Fused protein with antitumor effect

Info

Publication number
AU2000257080A1
AU2000257080A1 AU2000257080A AU5708000A AU2000257080A1 AU 2000257080 A1 AU2000257080 A1 AU 2000257080A1 AU 2000257080 A AU2000257080 A AU 2000257080A AU 5708000 A AU5708000 A AU 5708000A AU 2000257080 A1 AU2000257080 A1 AU 2000257080A1
Authority
AU
Australia
Prior art keywords
antitumor effect
fused protein
fused
protein
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000257080A
Inventor
Toshio Kudo
Izumi Kumagai
Masanori Suzuki
Kouhei Tsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tohoku Techno Arch Co Ltd
Original Assignee
Tohoku Techno Arch Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tohoku Techno Arch Co Ltd filed Critical Tohoku Techno Arch Co Ltd
Publication of AU2000257080A1 publication Critical patent/AU2000257080A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/626—Diabody or triabody
AU2000257080A 2000-06-30 2000-06-30 Fused protein with antitumor effect Abandoned AU2000257080A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2000/004389 WO2002006486A1 (en) 2000-06-30 2000-06-30 Fused protein with antitumor effect

Publications (1)

Publication Number Publication Date
AU2000257080A1 true AU2000257080A1 (en) 2002-01-30

Family

ID=11736210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000257080A Abandoned AU2000257080A1 (en) 2000-06-30 2000-06-30 Fused protein with antitumor effect

Country Status (2)

Country Link
AU (1) AU2000257080A1 (en)
WO (1) WO2002006486A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3803790B2 (en) 2003-02-17 2006-08-02 株式会社東北テクノアーチ Novel diabody-type bispecific antibody
US9315578B2 (en) 2006-03-23 2016-04-19 Tohoku Univeristy High functional bispecific antibody
JP5818003B2 (en) * 2009-11-18 2015-11-18 国立大学法人東北大学 High-functional variant of humanized anti-EGFR antibody variable region
CN105367660B (en) * 2015-12-22 2018-12-21 深圳市北科生物科技有限公司 A kind of bispecific antibody of anti-CD16A antigen and anti-MUC1 antigen

Also Published As

Publication number Publication date
WO2002006486A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2001232799A1 (en) Protein c derivatives
AU2001291049A1 (en) Defensin-antigen fusion proteins
AU2001273639A1 (en) Aryl fused substituted 4-oxy-pyridines
AU2001269888A1 (en) Protein phosphatases
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2001283012A1 (en) Protein phosphatases
AU2001290641A1 (en) Substituted fused pyrroleimines and pyrazoleimines
AU2000257080A1 (en) Fused protein with antitumor effect
AU2001292870A1 (en) Protein phosphatases
AU2001273208A1 (en) Proteins associated with aging
AU2001274676A1 (en) Plant-signalling ligand like proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU6983000A (en) Chimeric proteins
AU2002240889A1 (en) Proteins that interact with betatrcp
AU2001262589A1 (en) Glycosyltransferase proteins
AU2002211475A1 (en) Site-specific protein modification
AU2001278777A1 (en) Irap-binding protein
AU2001241044A1 (en) Mitf-associated proteins
AU2001261039A1 (en) Protein phosphatases
AU2001263445A1 (en) Methods for protein design
AU2001285246A1 (en) Search-on-the-fly with merge function
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2001272440A1 (en) Glass body
AU2001261423A1 (en) Vasodilator-thrombolytic fusion proteins and conjugates